These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Antioxidant action of 7,8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cytotoxicity. Han X; Zhu S; Wang B; Chen L; Li R; Yao W; Qu Z Neurochem Int; 2014 Jan; 64():18-23. PubMed ID: 24220540 [TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Saito Y; Nishio K; Ogawa Y; Kinumi T; Yoshida Y; Masuo Y; Niki E Free Radic Biol Med; 2007 Mar; 42(5):675-85. PubMed ID: 17291991 [TBL] [Abstract][Full Text] [Related]
32. Effect of chromium on oxygen free radical metabolism, inhibition of superoxide dismutase and enhancement of 6-hydroxydopamine oxidation. Shainkin-Kestenbaum R; Caruso C; Berlyne GM J Trace Elem Electrolytes Health Dis; 1991 Sep; 5(3):197-201. PubMed ID: 1821722 [TBL] [Abstract][Full Text] [Related]
33. Regional effects of 6-hydroxydopamine (6-OHDA) on free radical scavengers in rat brain. Perumal AS; Tordzro WK; Katz M; Jackson-Lewis V; Cooper TB; Fahn S; Cadet JL Brain Res; 1989 Dec; 504(1):139-41. PubMed ID: 2513085 [TBL] [Abstract][Full Text] [Related]
34. 6-Hydroxydopamine toxicity to dopamine neurons in culture: potentiation by the addition of superoxide dismutase and N-acetylcysteine. Mytilineou C; Danias P Biochem Pharmacol; 1989 Jun; 38(11):1872-5. PubMed ID: 2735944 [No Abstract] [Full Text] [Related]
35. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone. Li Y; Kuppusamy P; Zweir JL; Trush MA Mol Pharmacol; 1996 Mar; 49(3):412-21. PubMed ID: 8643080 [TBL] [Abstract][Full Text] [Related]
36. 6-hydroxydopamine does not reduce molecular oxygen directly, but requires a coreductant. Gee P; Davison AJ Arch Biochem Biophys; 1984 May; 231(1):164-8. PubMed ID: 6426392 [TBL] [Abstract][Full Text] [Related]
37. Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Emdadul Haque M; Asanuma M; Higashi Y; Miyazaki I; Tanaka K; Ogawa N Biochim Biophys Acta; 2003 Jan; 1619(1):39-52. PubMed ID: 12495814 [TBL] [Abstract][Full Text] [Related]
38. Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. Asanuma M; Hirata H; Cadet JL Neuroscience; 1998 Aug; 85(3):907-17. PubMed ID: 9639283 [TBL] [Abstract][Full Text] [Related]
39. Modification of the 6-hydroxydopamine technique for the correct determination of superoxide dismutase. Crosti N; Servidei T; Bajer J; Serra A J Clin Chem Clin Biochem; 1987 Apr; 25(4):265-6. PubMed ID: 3114411 [TBL] [Abstract][Full Text] [Related]
40. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Iida M; Miyazaki I; Tanaka K; Kabuto H; Iwata-Ichikawa E; Ogawa N Brain Res; 1999 Aug; 838(1-2):51-9. PubMed ID: 10446316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]